IFI-B · Indole Glucosinolate Modulation Series

Specimen SS-F-BTR-335 // ZERO-BITTER · IFI-B

Indole-GLS Mod · T2 Cell-Free-A

Brassica oleracea

Broccoli/Kale

Tier IIIndole Glucosinolate Modulation Series

Target Trait

39%

% reduction

Indole GLS (neoglucobrassicin) reduction

Technical Specifications

SKU

SS-F-BTR-335

Genomic Edits

4

GC Content

45.4%

Construct Length

2,877 bp

Promoter System

T7 / SP6 RNA polymerase

Expression System

Cell-free in vitro transcription/translation

Host Strain

In vitro wheat germ extract

Receptor Target

TAS2R38 (suppression)

IFI Score

39

Pathway Edits

  • CYP79B2 RNAi suppresses Trp-to-indole-3-acetaldoxime conversion at the indole GLS entry step
  • CYP79B3 RNAi provides redundant silencing coverage of the IAOx branch
  • MYB34 transcriptional repressor overexpression down-regulates indole GLS biosynthetic network

Key Interventions

CYP79B2 RNAi silencingCYP79B3 RNAiMYB34 overexpression

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
39
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier II kale and broccoli lines with specifically reduced indole glucosinolate burden, designed for formulations where aliphatic GLS flavor notes are desired but neoglucobrassicin-associated bitterness is objectionable.

License

$699 · Tier II License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?